EP
BSTC

Eversept Partners’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Eversept Partners’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-22,000
Closed -$1.33M – 69
2018
Q4 		$1.33M Buy
22,000
+100
+0.5% +$5.97K 0.72% 28
2018
Q3 		$1.28M Buy
+21,900
New +$1.12M 0.56% 31

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Eversept Partners's BSTC Position: Q1 2019 in Review

Eversept Partners sold out of BioSpecifics Technologies Corp. (BSTC) in Q1 2019, closing a stake of 22,000 shares — an estimated $1.33M sold.

Eversept Partners first reported a position in BSTC in Q3 2018 and held it in 2 quarters. The position peaked at $1.33M in Q4 2018. 117 funds tracked by Wall St. Rank hold BSTC as of Q1 2019.

  • Eversept Partners reported no remaining BioSpecifics Technologies Corp. position as of Q1 2019 after selling out during the quarter.
  • Eversept Partners sold 22,000 BioSpecifics Technologies Corp. shares in Q1 2019, an estimated $1.33M.
  • Eversept Partners first reported a position in BioSpecifics Technologies Corp. in Q3 2018 and held it in 2 quarters.
  • Eversept Partners's BioSpecifics Technologies Corp. position peaked at $1.33M in Q4 2018.
  • 117 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2019.

Based on Eversept Partners's 13F filing for Q1 2019, filed 14 May 2019.